the course of the surgery, a sclero-corneal drainage channel is created to reduce intraocular pressure.

MIMS is a microfluidic full-thickness procedure developed as an advanced laser sclerotomy. The technique uses a cutting and drilling device to reduce trauma to the surrounding tissue, minimizing scar tissue formation and allowing for a long-lasting filtering bleb. The MIMS channel ensures a controlled fluid flow with minor complications.

The company was founded in 2012 and is based in Tel Aviv, Israel